SANGRIX INC.
corporate_fare Company Profile
SANGRIX INC. (NASDAQ:SGRX) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 7 items for SGRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for SGRX spans 6-K, 6-K/A, 20-F.
Recent high-impact activity:
- Sangrix 1-for-8 Reverse Split Effective; Debenture and Warrant Resets Disclosed
- Sangrix Noteholders Convert $3.3M Principal Plus $209,807 Interest Into 2.15M Shares
- Sangrix Cuts Reverse-Split Ratio to 8-for-1 Ahead of Nov 3 Vote; Discloses Debenture and Warrant Price Resets
- Sangrix Sets Nov 3 Vote on 10-for-1 Reverse Split to Avoid Nasdaq Delisting
- Sangrix CEO Jiang Buys 75,000 Class B Shares at $0.4390, Reaching ~35% Voting Power
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 58,354 shares in SGRX as of the October 30, 2026 settlement, a 10.3% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 29.3% of SGRX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
SGRX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.